News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Study: Early lesions point to future secondary progressive MS

November 18, 2019

The findings suggest infratentorial lesions and deep white matter lesions at year one were the strongest early predictors of secondary progressive MS at 30 years.
Learn more

Study: Molecule may slow progression of MS

November 15, 2019

Results could lead to the development of a new generation of therapies to treat this autoimmune disease.
Learn more

Depressed MS patients suffer debilitating symptoms earlier

November 13, 2019

The findings highlight the need for early recognition and treatment of depressive symptoms in patients with MS.
Learn more

Study suggests potential genetic markers of MS-related vision loss

November 01, 2019

Authors said they could serve as markers for monitoring and predicting progression and severity of MS.
Learn more

FDA approves Vumerity MS

October 31, 2019

Vumerity (diroximel fumarate) approved for the treatment of relapsing forms of MS
Learn more

Researchers: Risk factors for unemployment with MS vary by age

October 24, 2019

Findings suggest that physical symptoms and how the individual manages them are greater issues for the youngest and oldest individuals.
Learn more

Study: Oligodendrocyte cells surprise contributor to MS

October 09, 2019

The discovery suggests new avenues for devising treatments and is a vital step toward finding a cure.
Learn more

Targeting subset of T cells prevents, reverses MS in mice

October 07, 2019

If the findings bear out in human studies, targeting these rogue T cells could effectively treat MS, the researchers believe.
Learn more

Study: Neuropsychological tests useful tool for real life activity in MS

September 23, 2019

Neuropsychological assessment was found to be among the tools useful for measuring the effect of MS on everyday activities.
Learn more

Study: Early lesions point to future secondary progressive MS

November 18, 2019

The findings suggest infratentorial lesions and deep white matter lesions at year one were the strongest early predictors of secondary progressive MS at 30 years.
Learn more

Study: Molecule may slow progression of MS

November 15, 2019

Results could lead to the development of a new generation of therapies to treat this autoimmune disease.
Learn more

Depressed MS patients suffer debilitating symptoms earlier

November 13, 2019

The findings highlight the need for early recognition and treatment of depressive symptoms in patients with MS.
Learn more

Study suggests potential genetic markers of MS-related vision loss

November 01, 2019

Authors said they could serve as markers for monitoring and predicting progression and severity of MS.
Learn more

FDA approves Vumerity MS

October 31, 2019

Vumerity (diroximel fumarate) approved for the treatment of relapsing forms of MS
Learn more

Researchers: Risk factors for unemployment with MS vary by age

October 24, 2019

Findings suggest that physical symptoms and how the individual manages them are greater issues for the youngest and oldest individuals.
Learn more

Study: Oligodendrocyte cells surprise contributor to MS

October 09, 2019

The discovery suggests new avenues for devising treatments and is a vital step toward finding a cure.
Learn more

Targeting subset of T cells prevents, reverses MS in mice

October 07, 2019

If the findings bear out in human studies, targeting these rogue T cells could effectively treat MS, the researchers believe.
Learn more

Study: Neuropsychological tests useful tool for real life activity in MS

September 23, 2019

Neuropsychological assessment was found to be among the tools useful for measuring the effect of MS on everyday activities.
Learn more

Data: Ocrevus treatment reduced MS disability progression

September 18, 2019

Results suggest earlier treatment with Ocrevus reduced the risk of disability progression and this effect was sustained over time. Additionally, new safety data remain consistent with the medicine’s favorable benefit-risk profile. 
Learn more

Ocrevus biomarker data may improve understanding of MS progression

September 12, 2019

Researchers found that blood neurofilament light chain levels were significantly lowered following Ocrevus treatment in analyses of Phase III studies in relapsing and primary progressive MS.
Learn more

New app offers faster and easier MS assessment

September 10, 2019

The researchers said a tablet-based test saves time, is easier to administer, eliminates the need to store paper-based records, and makes sharing information easier on electronic medical records.
Learn more

AAN issues guideline on vaccines and MS

August 29, 2019

Guideline recommends that people with MS receive recommended vaccinations, including yearly flu shots.
Learn more

Medicare patients with MS bear the burden of rising drug prices

August 27, 2019

According to the study, Medicare spending increased by more than tenfold from 2006-2016, and the patients themselves saw more than a sevenfold increase in their share of the bill.
Learn more

Smoldering spots in the brain may signal severe MS

August 13, 2019

Researchers said results support the idea that chronic active lesions are very damaging to the brain and the need to attack these lesions as early as possible.
Learn more

Forgotten immune cells protective in mouse model of MS

August 09, 2019

Stimulating these protective cells could lead to new therapies for multiple sclerosis.
Learn more

Study: Vaccinations not a risk factor for MS

August 02, 2019

Researchers found no link between vaccinations and the development of MS.
Learn more

MS Focus children’s book author seeks reader feedback

July 25, 2019

This publication is currently in stock and available for order. As with all MS Focus publications, the book and shipping is completely free.
Learn more


Show More News